The demand for cardiovascular ultrasound in USA is projected to grow from USD 0.5 billion in 2025 to USD 1.0 billion by 2035, at a CAGR of 6.5%. Transthoracic Echocardiography will dominate with a 45.2% market share, while 2d will lead the technology segment with a 48.7% share.